FDA Seeks Public Comment on Proposed Survey of Mammography Facilities

Summary

The Food and Drug Administration (FDA) is seeking public comment on a proposed survey of mammography facilities to assess the impact of the Mammography Quality Standards Act (MQSA) on access to mammography services. The FDA is required to publish this notice under the Paperwork Reduction Act of 1995 (PRA), which allows for a 60-day public comment period.